UPenn Pioneer Bruce Levine on CAR-T Treatment in 2023 | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

  • Please accept my sincerest apologies for failing to publicly acknowledge our fallen heroes this past Memorial Day. No excuse I could offer could justify the oversight. Along with you, I salute the many men and women who have proudly and selflessly served in our military to protect, defend and secure the freedoms and liberties we enjoy each and every day. Their bravery in making the ultimate sacrifice will forever be appreciated and they will always be remembered and celebrated and never taken for granted or forgotten.


BMY   /  Message Board  /  Read Message

 
BOARD

GROUPS
 










Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board
Msg  10794 of 11270  at  2/5/2023 11:03:35 AM  by

JBWIN


UPenn Pioneer Bruce Levine on CAR-T Treatment in 2023

 
 
 
 BMY's capacity growth for both Abecma/Ide-cel and Breyanzi/Liso-cel in addition to positive earlier line data for both products and positive top-line CLL Breyanzi data should help drive sales.
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 10  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board




Financial Market Data provided by
.
Loading...